A Study in Participants With Advanced Solid Tumors

NCT01682135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: Ramucirumab

Sponsor

Eli Lilly and Company